United States Biotechnology & Medical Research

Argos Therapeutics Inc (ARGSQ)

Track

Ticker: ARGSQ Exchange: OTC
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Planned sale 9 Jan 2018
Value US$219,334.91 | Price 42.05 | Shares 96,370 (+45.0%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2018-01-12 2018-01-09 PlS Planned sale Katz Richard D

Vice President and CFO

Officer
96,370 +45.0%
42.05
US$219,335 		96,370 +45.0% 42.05 US$219,335
2018-01-12 2018-01-09 PlS Planned sale Harrelson Lori R.

Vice President of Finance

Officer
54,319 +12.5%
335.60
US$1,213,556 		54,319 +12.5% 335.60 US$1,213,556
2018-01-12 2018-01-09 PlS Planned sale Abbey Jeffrey D

President, CEO

Executive Director
49,765 +13.1%
211.50
US$3,516,129 		49,765 +13.1% 211.50 US$3,516,129
2018-01-12 2018-01-09 PlS Planned sale Nicolette Charles A.

CSO and Vice President of R&D

Officer
100,250 -20.0%
0.16
US$16,501 		100,250 -20.0% 0.16 US$16,501
2018-01-05 2018-01-03 PlS Planned sale Harrelson Lori R.

Vice President of Finance

Officer
59,072 -16.7%
0.16
US$9,658 		59,072 -16.7% 0.16 US$9,658
2018-01-05 2018-01-03 PlS Planned sale Abbey Jeffrey D

President, CEO

Executive Director
114,702 -15.3%
0.16
US$18,719 		114,702 -15.3% 0.16 US$18,719
2018-01-05 2018-01-03 PlS Planned sale Abbey Jeffrey D

President, CEO

Executive Director
114,702 -15.3%
0.16
US$18,719 		114,702 -15.3% 0.16 US$18,719
2018-01-05 2018-01-03 PlS Planned sale Katz Richard D

Vice President and CFO

Officer
101,228 -25.3%
0.16
US$16,541 		101,228 -25.3% 0.16 US$16,541
2018-01-05 2018-01-03 PlS Planned sale Nicolette Charles A.

CSO and Vice President of R&D

Officer
92,001 -15.5%
0.16
US$15,061 		92,001 -15.5% 0.16 US$15,061
2016-10-13 2016-10-07 B Purchase Pharmstandard International S.A. Large shareholder
21,000 +0.2%
4.73
US$99,330 		21,000 +0.2% 4.73 US$99,330
2016-10-13 2016-10-06 B Purchase Pharmstandard International S.A. Large shareholder
2,640 +0.0%
4.81
US$12,698 		2,640 +0.0% 4.81 US$12,698
2016-10-13 2016-10-05 B Purchase Pharmstandard International S.A. Large shareholder
900 +0.0%
4.85
US$4,365 		900 +0.0% 4.85 US$4,365
2016-10-13 2016-10-04 B Purchase Pharmstandard International S.A. Large shareholder
7,164 +0.1%
4.69
US$33,599 		7,164 +0.1% 4.69 US$33,599
2016-10-04 2016-10-03 B Purchase Pharmstandard International S.A. Large shareholder
11,308 +0.1%
4.70
US$53,148 		11,308 +0.1% 4.70 US$53,148
2016-10-04 2016-09-30 B Purchase Pharmstandard International S.A. Large shareholder
30,232 +0.2%
4.71
US$142,393 		30,232 +0.2% 4.71 US$142,393
2016-09-30 2016-09-29 B Purchase Pharmstandard International S.A. Large shareholder
15,100 +0.1%
4.60
US$69,460 		15,100 +0.1% 4.60 US$69,460
2016-09-30 2016-09-28 B Purchase Pharmstandard International S.A. Large shareholder
28,518 +0.2%
4.54
US$129,472 		28,518 +0.2% 4.54 US$129,472
2016-09-21 2016-09-20 B Purchase Pharmstandard International S.A. Large shareholder
41,259 +0.3%
4.77
US$196,805 		41,259 +0.3% 4.77 US$196,805
2016-09-21 2016-09-19 B Purchase Pharmstandard International S.A. Large shareholder
5,580 +0.0%
4.76
US$26,561 		5,580 +0.0% 4.76 US$26,561
2016-09-20 2016-09-16 B Purchase Pharmstandard International S.A. Large shareholder
36,632 +0.3%
4.78
US$175,101 		36,632 +0.3% 4.78 US$175,101
2016-09-20 2016-09-15 B Purchase Pharmstandard International S.A. Large shareholder
15,880 +0.1%
4.76
US$75,589 		15,880 +0.1% 4.76 US$75,589
2016-09-07 2016-09-01 B Purchase Pharmstandard International S.A. Large shareholder
16,977 +0.1%
4.78
US$81,150 		16,977 +0.1% 4.78 US$81,150
2016-08-29 2016-08-24 B Purchase Pharmstandard International S.A. Large shareholder
55,224 +0.4%
4.57
US$252,374 		55,224 +0.4% 4.57 US$252,374
2016-08-25 2016-08-24 B Purchase Pharmstandard International S.A. Large shareholder
57,772 +0.4%
4.55
US$262,863 		57,772 +0.4% 4.55 US$262,863
2016-08-25 2016-08-23 B Purchase Pharmstandard International S.A. Large shareholder
9,599 +0.1%
4.36
US$41,852 		9,599 +0.1% 4.36 US$41,852
2016-08-23 2016-08-22 B Purchase Pharmstandard International S.A. Large shareholder
21,950 +0.2%
4.26
US$93,507 		21,950 +0.2% 4.26 US$93,507
2016-08-23 2016-08-19 B Purchase Pharmstandard International S.A. Large shareholder
53,524 +0.4%
4.23
US$226,407 		53,524 +0.4% 4.23 US$226,407
2016-08-04 2016-08-02 B Purchase van Deventer Sander Non-Executive Director Large shareholder
1,545,454
0.00
US$0 		1,545,454 0.00 US$0
2016-08-04 2016-08-02 B Purchase Pharmstandard International S.A. Large shareholder
2,363,636
0.00
US$0 		2,363,636 0.00 US$0
2016-08-04 2016-08-02 B Purchase ForArgos B.V. Large shareholder
1,545,454
0.00
US$0 		1,545,454 0.00 US$0
2016-07-01 2016-06-29 B Purchase Birner Hubert Non-Executive Director
275,545
0.00
US$0 		275,545 0.00 US$0
2016-07-01 2016-06-29 B Purchase van Deventer Sander Non-Executive Director Large shareholder
1,322,618
0.00
US$0 		1,322,618 0.00 US$0
2016-07-01 2016-06-29 B Purchase Pharmstandard International S.A. Large shareholder
2,678,301
0.00
US$0 		2,678,301 0.00 US$0
2016-07-01 2016-06-29 B Purchase ForArgos B.V. Large shareholder
1,322,618
0.00
US$0 		1,322,618 0.00 US$0
2016-03-16 2016-03-14 B Purchase
Birner Hubert
Non-Executive Director
183,697
0.00
US$0 		183,697 0.00 US$0
2016-03-16 2016-03-14 B Purchase
van Deventer Sander
Non-Executive Director Large shareholder
881,745
0.00
US$0 		881,745 0.00 US$0
2016-03-16 2016-03-14 B Purchase Pharmstandard International S.A. Large shareholder
1,785,534
0.00
US$0 		1,785,534 0.00 US$0
2015-12-17 2015-12-16 B Purchase Petrov Andrei Vladimirovich Non-Executive Director
5,000 +inf%
1.80
US$9,000 		5,000 +inf% 1.80 US$9,000
2015-12-17 2015-12-16 B Purchase Winterbottom Joan

Chief Human Resources Officer

Officer
250 +100.0%
1.83
US$458 		250 +100.0% 1.83 US$458
2015-12-16 2015-12-15 B Purchase Vinogradov Alexey Alexandrovich Non-Executive Director
2,000 +inf%
2.15
US$4,300 		2,000 +inf% 2.15 US$4,300
2015-12-17 2015-12-14 B Purchase Abbey Jeffrey D

CEO

Executive Director
5,000 +90.9%
2.50
US$12,486 		5,000 +90.9% 2.50 US$12,486
2015-12-16 2015-12-14 B Purchase Winterbottom Joan

Chief Human Resources Officer

Officer
50 +25.0%
2.15
US$107 		50 +25.0% 2.15 US$107
2015-12-16 2015-12-14 B Purchase Winterbottom Joan

Chief Human Resources Officer

Officer
100 +100.0%
2.15
US$214 		100 +100.0% 2.15 US$214
2015-12-16 2015-12-14 B Purchase Winterbottom Joan

Chief Human Resources Officer

Officer
100 +inf%
2.15
US$215 		100 +inf% 2.15 US$215
2015-11-25 2015-11-24 B Purchase Van Holle Philippe Marie Marcel Joseph Non-Executive Director
5,000 +12.5%
4.25
US$21,250 		5,000 +12.5% 4.25 US$21,250
2015-11-25 2015-11-24 B Purchase Van Holle Philippe Marie Marcel Joseph Non-Executive Director
5,000 +14.2%
4.30
US$21,500 		5,000 +14.2% 4.30 US$21,500
2015-11-23 2015-11-19 B Purchase Van Holle Philippe Marie Marcel Joseph Non-Executive Director
10,000 +39.8%
4.15
US$41,511 		10,000 +39.8% 4.15 US$41,511
2015-11-23 2015-11-19 B Purchase Abbey Jeffrey D

CEO

Executive Director
1,000 +18.2%
4.08
US$4,080 		1,000 +18.2% 4.08 US$4,080
2015-09-04 2015-09-03 B Purchase Van Holle Philippe Marie Marcel Joseph Non-Executive Director
6,000 +31.4%
6.31
US$37,843 		6,000 +31.4% 6.31 US$37,843
2015-09-04 2015-09-02 B Purchase Van Holle Philippe Marie Marcel Joseph Non-Executive Director
6,000 +45.8%
6.22
US$37,342 		6,000 +45.8% 6.22 US$37,342
2015-09-02 2015-09-01 B Purchase Van Holle Philippe Marie Marcel Joseph Non-Executive Director
5,000 +61.7%
6.26
US$31,318 		5,000 +61.7% 6.26 US$31,318
2015-08-26 2015-08-25 B Purchase Lamarre Jean Non-Executive Director
2,500 +inf%
6.14
US$15,353 		2,500 +inf% 6.14 US$15,353
2015-08-27 2015-08-24 B Purchase Winterbottom Joan

Chief Human Resources Officer

Officer
100 +11.1%
6.09
US$609 		100 +11.1% 6.09 US$609
2015-08-27 2015-08-24 B Purchase Winterbottom Joan

Chief Human Resources Officer

Officer
900 +inf%
6.10
US$5,490 		900 +inf% 6.10 US$5,490
2015-08-27 2015-08-20 B Purchase Van Holle Philippe Marie Marcel Joseph Non-Executive Director
5,000 +161.3%
5.80
US$29,024 		5,000 +161.3% 5.80 US$29,024
2015-08-27 2015-08-20 B Purchase Nicolette Charles A.

Chief Scientific Officer

Officer
5,000 +61.5%
6.45
US$32,250 		5,000 +61.5% 6.45 US$32,250
2015-08-27 2015-08-19 B Purchase Van Holle Philippe Marie Marcel Joseph Non-Executive Director
3,100 +inf%
4.73
US$14,654 		3,100 +inf% 4.73 US$14,654
2015-08-21 2015-08-19 B Purchase Abbey Jeffrey D

CEO

Executive Director
5,500 +inf%
4.75
US$26,149 		5,500 +inf% 4.75 US$26,149
2014-02-12 2014-02-12 B Purchase Cooperatieve AAC LS U.A. Large shareholder
36,416 +1.5%
8.00
US$291,328 		36,416 +1.5% 8.00 US$291,328
2014-02-12 2014-02-12 B Purchase Underdown Brian J. Non-Executive Director Large shareholder
40,497 +3.3%
8.00
US$323,976 		40,497 +3.3% 8.00 US$323,976
2014-02-12 2014-02-12 B Purchase Pharmstandard International S.A. Large shareholder
1,275,000 +27.1%
8.00
US$10,200,000 		1,275,000 +27.1% 8.00 US$10,200,000
2014-02-12 2014-02-12 B Purchase Birner Hubert Non-Executive Director Large shareholder
39,873 +2.8%
8.00
US$318,984 		39,873 +2.8% 8.00 US$318,984
2014-02-12 2014-02-12 B Purchase van Deventer Sander Non-Executive Director Large shareholder
36,416 +1.5%
8.00
US$291,328 		36,416 +1.5% 8.00 US$291,328
Explore more

More insider trading research around Argos Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America